NANO-X IMAGING LTD
As of Oct 22, 2026, NANO-X IMAGING is in Stage 4, the downtrend phase, now in week 62 (since Jul 31, 2025). It closed at $0.38, 91.6% below its 52-week high and below its 200-day average, which is falling.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is NNOX early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
NNOX among Medical Devices119th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …119 | NNOX | Stage 4 · wk 62 | 7 | −45.0% |
NANO-X IMAGING: quick answers
What stage is NANO-X IMAGING in?
As of Oct 22, 2026, NANO-X IMAGING (NNOX) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 31, 2025 and is in week 62. What the four stages mean
Is NANO-X IMAGING in an uptrend?
No. NANO-X IMAGING is in a Stage 4 downtrend. It trades 77.1% below its 200-day average, which is falling.
How far is NANO-X IMAGING from its 52-week high?
NANO-X IMAGING closed at $0.38 on Oct 22, 2026, 91.6% below its 52-week high of $4.55. Its 52-week low is $0.38.
How has NANO-X IMAGING performed over the past year?
As of Oct 22, 2026, NANO-X IMAGING is down 90.6% over the past year and down 86.4% so far in 2026.
Which sector and industry is NANO-X IMAGING in?
NANO-X IMAGING is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligencebased solution; AI-Based Body Composition Measurement, an artificial intelligencebased body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.